Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionality is currently unavailable.

David Eric Shapiro, Ph.D.

Title
Institution
Department
Address
Phone
Other Positions
Title
Institution
Department

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U01AI068616 (SHAPIRO, DAVID ERIC) Aug 13, 2009 - Sep 26, 2012
    NIH/NIAID
    Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTG
    Role: Principal Investigator
  2. UM1AI068616 (SHAPIRO, DAVID ERIC) Jun 29, 2006 - Nov 30, 2020
    NIH/NIAID
    SDMC - IMPAACT Leadership Group
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. João EC, Morrison RL, Shapiro DE, Chakhtoura N, Gouvèa MIS, de Lourdes B Teixeira M, Fuller TL, Mmbaga BT, Ngocho JS, Njau BN, Violari A, Mathiba R, Essack Z, Pilotto JHS, Moreira LF, Rolon MJ, Cahn P, Prommas S, Cressey TR, Chokephaibulkit K, Werarak P, Laimon L, Hennessy R, Frenkel LM, Anthony P, Best BM, Siberry GK, Mirochnick M. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial. Lancet HIV. 2020 05; 7(5):e322-e331. PMID: 32386720.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  2. Eke AC, Stek AM, Wang J, Kreitchmann R, Shapiro DE, Smith E, Chakhtoura N, Capparelli EV, Mirochnick M, Best BM. Darunavir Pharmacokinetics With an Increased Dose During Pregnancy. . 2020 04 01; 83(4):373-380. PMID: 31923087.
    Citations: 2     Translation:HumansCells
  3. Eke AC, Wang J, Amin K, Shapiro DE, Stek A, Smith E, Chakhtoura N, Basar M, George K, Knapp KM, João EC, Rungruengthanakit K, Capparelli E, Burchett S, Mirochnick M, Best BM. Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy. Antimicrob Agents Chemother. 2020 03 24; 64(4). PMID: 32015036.
    Citations: 2     Fields:    
  4. Angelidou K, Fowler MG, Flynn P, Coletti A, McCarthy K, Browning R, McIntyre J, Brummel SS, Shapiro DE, Tierney C. Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions. Clin Trials. 2020 Aug; 17(4):437-447. PMID: 32191142.
    Citations:    Fields:    
  5. Hoffman RM, Angelidou KN, Brummel SS, Saidi F, Violari A, Dula D, Mave V, Fairlie L, Theron G, Kamateeka M, Chipato T, Chi BH, Stranix-Chibanda L, Nematadzira T, Moodley D, Bhattacharya D, Gupta A, Coletti A, McIntyre JA, Klingman KL, Chakhtoura N, Shapiro DE, Fowler MG, Currier JS. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV Clin Trials. 2018 12; 19(6):209-224. PMID: 30890061.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  6. Momper JD, Best BM, Wang J, Capparelli EV, Stek A, Barr E, Badell ML, Acosta EP, Purswani M, Smith E, Chakhtoura N, Park K, Burchett S, Shapiro DE, Mirochnick M. Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV. AIDS. 2018 11 13; 32(17):2507-2516. PMID: 30134297.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  7. Venkatesh KK, Morrison L, Livingston EG, Stek A, Read JS, Shapiro DE, Tuomala RE. Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States. Obstet Gynecol. 2018 05; 131(5):879-890. PMID: 29630021.
    Citations: 1     Fields:    Translation:Humans
  8. Rough K, Seage GR, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Currier JS, Hoffman RM, Barr E, Shapiro DE, Patel K. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine. N Engl J Med. 2018 04 26; 378(17):1593-1603. PMID: 29694825.
    Citations: 3     Fields:    Translation:Humans
  9. Flynn PM, Taha TE, Cababasay M, Fowler MG, Mofenson LM, Owor M, Fiscus S, Stranix-Chibanda L, Coutsoudis A, Gnanashanmugam D, Chakhtoura N, McCarthy K, Mukuzunga C, Makanani B, Moodley D, Nematadzira T, Kusakara B, Patil S, Vhembo T, Bobat R, Mmbaga BT, Masenya M, Nyati M, Theron G, Mulenga H, Butler K, Shapiro DE. Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial. . 2018 04 01; 77(4):383-392. PMID: 29239901.
    Citations: 10     Translation:Humans
  10. Balasubramanian R, Fowler MG, Dominguez K, Lockman S, Tookey PA, Huong NNG, Nesheim S, Hughes MD, Lallemant M, Tosswill J, Shaffer N, Sherman G, Palumbo P, Shapiro DE. Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1. AIDS. 2017 11 28; 31(18):2465-2474. PMID: 28926397.
    Citations: 3     Fields:    Translation:HumansCells
  11. Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016 11 03; 375(18):1726-1737. PMID: 27806243.
    Citations: 62     Fields:    Translation:Humans
  12. Tran AH, Best BM, Stek A, Wang J, Capparelli EV, Burchett SK, Kreitchmann R, Rungruengthanakit K, George K, Cressey TR, Chakhtoura N, Smith E, Shapiro DE, Mirochnick M. Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women. . 2016 07 01; 72(3):289-96. PMID: 26918544.
    Citations: 5     Translation:HumansCTClinical Trials
  13. Olson SC, Ngo-Giang-Huong N, Beck I, Deng W, Britto P, Shapiro DE, Bumgarner RE, Mullins JI, Van Dyke RB, Jourdain G, Frenkel LM. Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission. AIDS. 2015 Jul 31; 29(12):1467-71. PMID: 26244386.
    Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
  14. Katz IT, Shapiro DE, Tuomala R. Factors Associated With Lack of Viral Suppression at Delivery. Ann Intern Med. 2015 Jun 16; 162(12):874-5. PMID: 26075762.
    Citations: 1     Fields:    Translation:Humans
  15. Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Ann Intern Med. 2015 Jan 20; 162(2):90-9. PMID: 25599347.
    Citations: 11     Fields:    Translation:HumansCells
  16. Watts DH, Stek A, Best BM, Wang J, Capparelli EV, Cressey TR, Aweeka F, Lizak P, Kreitchmann R, Burchett SK, Shapiro DE, Hawkins E, Smith E, Mirochnick M. Raltegravir pharmacokinetics during pregnancy. . 2014 Dec 01; 67(4):375-81. PMID: 25162818.
    Citations: 16     Translation:HumansCTClinical Trials
  17. Cressey TR, Best BM, Achalapong J, Stek A, Wang J, Chotivanich N, Yuthavisuthi P, Suriyachai P, Prommas S, Shapiro DE, Watts DH, Smith E, Capparelli E, Kreitchmann R, Mirochnick M. Reduced indinavir exposure during pregnancy. Br J Clin Pharmacol. 2013 Sep; 76(3):475-83. PMID: 23305215.
    Citations: 8     Fields:    Translation:Humans
  18. Hoffman RM, Leister E, Kacanek D, Shapiro DE, Read JS, Bryson Y, Currier JS. Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery. . 2013 Aug 15; 63(5):593-601. PMID: 23714738.
    Citations:    Translation:HumansCTClinical Trials
  19. Kreitchmann R, Best BM, Wang J, Stek A, Caparelli E, Watts DH, Smith E, Shapiro DE, Rossi S, Burchett SK, Hawkins E, Byroads M, Cressey TR, Mirochnick M. Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy. . 2013 May 01; 63(1):59-66. PMID: 23392467.
    Citations: 12     Translation:HumansCellsCTClinical Trials
  20. Theron GB, Cababasay MP, Van Dyke RB, Shapiro DE, Louw J, Watts DH, Bulterys M, Styer LM, Maupin R. Prevalence of HIV among women entering labor who accepted or declined voluntary counseling and testing. Int J Gynaecol Obstet. 2013 Feb; 120(2):141-3. PMID: 23141415.
    Citations: 2     Fields:    Translation:Humans
  21. Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman KL, Shapiro DE, Mofenson L, Moran L, Campbell TB, Hitti J, Fiscus S, Currier J. Infant outcomes after maternal antiretroviral exposure in resource-limited settings. Pediatrics. 2012 Jun; 129(6):e1525-32. PMID: 22585772.
    Citations: 12     Fields:    Translation:HumansCellsCTClinical Trials
  22. Cuevas LE, Browning R, Bossuyt P, Casenghi M, Cotton MF, Cruz AT, Dodd LE, Drobniewski F, Gale M, Graham SM, Grzemska M, Heinrich N, Hesseling AC, Huebner R, Jean-Philippe P, Kabra SK, Kampmann B, Lewinsohn D, Li M, Lienhardt C, Mandalakas AM, Marais BJ, Menzies HJ, Montepiedra G, Mwansambo C, Oberhelman R, Palumbo P, Russek-Cohen E, Shapiro DE, Smith B, Soto-Castellares G, Starke JR, Swaminathan S, Wingfield C, Worrell C. Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J Infect Dis. 2012 May 15; 205 Suppl 2:S209-15. PMID: 22476719.
    Citations: 31     Fields:    Translation:Humans
  23. Knapp KM, Brogly SB, Muenz DG, Spiegel HM, Conway DH, Scott GB, Talbot JT, Shapiro DE, Read JS. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J. 2012 Feb; 31(2):164-70. PMID: 21983213.
    Citations: 18     Fields:    Translation:Humans
  24. Van Dyke RB, Ngo-Giang-Huong N, Shapiro DE, Frenkel L, Britto P, Roongpisuthipong A, Beck IA, Yuthavisuthi P, Prommas S, Puthanakit T, Achalapong J, Chotivanich N, Rasri W, Cressey TR, Maupin R, Mirochnick M, Jourdain G. A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine. Clin Infect Dis. 2012 Jan 15; 54(2):285-93. PMID: 22144539.
    Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
  25. Flynn PM, Mirochnick M, Shapiro DE, Bardeguez A, Rodman J, Robbins B, Huang S, Fiscus SA, Van Rompay KK, Rooney JF, Kearney B, Mofenson LM, Watts DH, Jean-Philippe P, Heckman B, Thorpe E, Cotter A, Purswani M. Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants. Antimicrob Agents Chemother. 2011 Dec; 55(12):5914-22. PMID: 21896911.
    Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
  26. Theron GB, Shapiro DE, Van Dyke R, Cababasay MP, Louw J, Watts DH, Smith E, Bulterys M, Maupin R. Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa. Int J Gynaecol Obstet. 2011 Apr; 113(1):44-9. PMID: 21251654.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  27. Patel K, Shapiro DE, Brogly SB, Livingston EG, Stek AM, Bardeguez AD, Tuomala RE. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis. 2010 Apr 01; 201(7):1035-44. PMID: 20196654.
    Citations: 40     Fields:    Translation:Humans
  28. Ouyang DW, Brogly SB, Lu M, Shapiro DE, Hershow RC, French AL, Leighty RM, Thompson B, Tuomala RE. Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals. AIDS. 2010 Jan 02; 24(1):109-14. PMID: 19926957.
    Citations: 9     Fields:    Translation:HumansCells
  29. Brogly SB, Foca M, Deville JG, Mirochnick M, Scott GB, Mofenson LM, Read JS, Viani RM, Burchett SK, Cooper ER, Browning R, Shapiro DE. Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants. . 2010 Jan; 53(1):154-7. PMID: 20035168.
    Citations: 4     Translation:HumansCells
  30. Ouyang DW, Shapiro DE, Lu M, Brogly SB, French AL, Leighty RM, Thompson B, Tuomala RE, Hershow RC. Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure. AIDS. 2009 Nov 27; 23(18):2425-30. PMID: 19617813.
    Citations: 12     Fields:    Translation:Humans
  31. Cressey TR, Van Dyke R, Jourdain G, Puthanakit T, Roongpisuthipong A, Achalapong J, Yuthavisuthi P, Prommas S, Chotivanich N, Maupin R, Smith E, Shapiro DE, Mirochnick M. Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women. Antimicrob Agents Chemother. 2009 May; 53(5):2189-91. PMID: 19237646.
    Citations: 3     Fields:    Translation:HumansCells
  32. Shapiro DE. Wiley Encyclopedia of Clinical Trials. Mother to Child Human Immunodeficiency Virus Transmission Trials. 2008. View Publication.
  33. Nielsen PE, Goldman MB, Mann S, Shapiro DE, Marcus RG, Pratt SD, Greenberg P, McNamee P, Salisbury M, Birnbach DJ, Gluck PA, Pearlman MD, King H, Tornberg DN, Sachs BP. Effects of teamwork training on adverse outcomes and process of care in labor and delivery: a randomized controlled trial. Obstet Gynecol. 2007 Jan; 109(1):48-55. PMID: 17197587.
    Citations: 39     Fields:    Translation:Humans
  34. Brogly S, Read JS, Shapiro D, Stek A, Tuomala R. Participation of HIV-infected pregnant women in research in the United States. AIDS Res Hum Retroviruses. 2007 Jan; 23(1):51-3. PMID: 17263632.
    Citations: 8     Fields:    Translation:Humans
  35. Mann S, Pratt S, Gluck P, Nielsen P, Risser D, Greenberg P, Marcus R, Goldman M, Shapiro D, Pearlman M, Sachs B. Assessing quality obstetrical care: development of standardized measures. Jt Comm J Qual Patient Saf. 2006 Sep; 32(9):497-505. PMID: 17987873.
    Citations: 28     Fields:    Translation:Humans
  36. Wade NA, Unadkat JD, Huang S, Shapiro DE, Mathias A, Yasin S, Ciupak G, Watts DH, Delke I, Rathore M, Hitti J, Frenkel L, Samelson R, Smith ME, Mofenson L, Burchett SK. Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332. J Infect Dis. 2004 Dec 15; 190(12):2167-74. PMID: 15551216.
    Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
  37. Ioannidis JP, Tatsioni A, Abrams EJ, Bulterys M, Coombs RW, Goedert JJ, Korber BT, Mayaux MJ, Mofenson LM, Moye J, Newell ML, Shapiro DE, Teglas JP, Thompson B, Wiener J. Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS. 2004 Jan 02; 18(1):99-108. PMID: 15090835.
    Citations: 8     Fields:    Translation:HumansCells
  38. Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, Huang S, Sperling RS, Cunningham B, Gandia J, Maupin R, Zorrilla CD, Jones T, O'Sullivan MJ. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. . 2003 Feb 01; 32(2):170-81. PMID: 12571527.
    Citations: 8     Translation:HumansCellsCTClinical Trials
  39. Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med. 2002 Jun 13; 346(24):1863-70. PMID: 12063370.
    Citations: 75     Fields:    Translation:HumansCTClinical Trials
  40. Ioannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L, Korber BT, Mayaux MJ, Mofenson LM, Newell ML, Shapiro DE, Teglas JP, Wilfert CM. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis. 2001 Feb 15; 183(4):539-45. PMID: 11170978.
    Citations: 49     Fields:    Translation:HumansCells
  41. Farr BM, Shapiro DE. Diagnostic tests: distinguishing good tests from bad and even ugly ones. Infect Control Hosp Epidemiol. 2000 Apr; 21(4):278-84. PMID: 10782593.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  42. Shapiro DE, Sperling RS, Mandelbrot L, Britto P, Cunningham BE. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group. Obstet Gynecol. 1999 Dec; 94(6):897-908. PMID: 10576173.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  43. Brambilla D, Reichelderfer PS, Bremer JW, Shapiro DE, Hershow RC, Katzenstein DA, Hammer SM, Jackson B, Collier AC, Sperling RS, Fowler MG, Coombs RW. The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program. AIDS. 1999 Nov 12; 13(16):2269-79. PMID: 10563712.
    Citations: 24     Fields:    Translation:HumansCells
  44. Gelber RD, Shapiro DE. Mode of delivery and the risk of vertical transmission of HIV-1. N Engl J Med. 1999 Jul 15; 341(3):206-7. PMID: 10409038.
    Citations:    Fields:    Translation:HumansCells
  45. Shapiro DE, Sperling RS, Coombs RW. Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load. Pediatric AIDS Clinical Trials Group 076 Study Group. Lancet. 1999 Jul 10; 354(9173):156; author reply 157-8. PMID: 10408505.
    Citations:    Fields:    Translation:HumansCells
  46. Shapiro DE. The interpretation of diagnostic tests. Stat Methods Med Res. 1999 Jun; 8(2):113-34. PMID: 10501649.
    Citations: 55     Fields:    Translation:Humans
  47. McSherry GD, Shapiro DE, Coombs RW, McGrath N, Frenkel LM, Britto P, Culnane M, Sperling RS. The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076). J Pediatr. 1999 Jun; 134(6):717-24. PMID: 10356140.
    Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
  48. Hanson IC, Antonelli TA, Sperling RS, Oleske JM, Cooper E, Culnane M, Fowler MG, Kalish LA, Lee SS, McSherry G, Mofenson L, Shapiro DE. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15; 20(5):463-7. PMID: 10225228.
    Citations: 14     Fields:    Translation:HumansCells
  49. Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM, Cunningham B, Oleske J. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA. 1999 Jan 13; 281(2):151-7. PMID: 9917118.
    Citations: 49     Fields:    Translation:HumansCellsCTClinical Trials
  50. Sperling RS, Shapiro DE, McSherry GD, Britto P, Cunningham BE, Culnane M, Coombs RW, Scott G, Van Dyke RB, Shearer WT, Jimenez E, Diaz C, Harrison DD, Delfraissy JF. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS. 1998 Oct 01; 12(14):1805-13. PMID: 9792381.
    Citations: 29     Fields:    Translation:HumansCellsCTClinical Trials
  51. Eastman PS, Shapiro DE, Coombs RW, Frenkel LM, McSherry GD, Britto P, Herman SA, Sperling RS. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. J Infect Dis. 1998 Mar; 177(3):557-64. PMID: 9498432.
    Citations: 21     Fields:    Translation:HumansCellsCTClinical Trials
  52. Mushlin AI, Kouides RW, Shapiro DE. Estimating the accuracy of screening mammography: a meta-analysis. Am J Prev Med. 1998 Feb; 14(2):143-53. PMID: 9631167.
    Citations: 30     Fields:    Translation:HumansPHPublic Health
  53. Brambilla D, Leung S, Lew J, Todd J, Herman S, Cronin M, Shapiro DE, Bremer J, Hanson C, Hillyer GV, McSherry GD, Sperling RS, Coombs RW, Reichelderfer PS. Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons. J Clin Microbiol. 1998 Jan; 36(1):311-4. PMID: 9431977.
    Citations: 15     Fields:    Translation:HumansCells
  54. Zou KH, Hall WJ, Shapiro DE. Smooth non-parametric receiver operating characteristic (ROC) curves for continuous diagnostic tests. Stat Med. 1997 Oct 15; 16(19):2143-56. PMID: 9330425.
    Citations: 37     Fields:    Translation:Humans
  55. Frenkel LM, Cowles MK, Shapiro DE, Melvin AJ, Watts DH, McLellan C, Mohan K, Murante B, Burchett S, Bryson YJ, O'Sullivan MJ, Mitchell C, Landers D. Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1. J Infect Dis. 1997 Apr; 175(4):971-4. PMID: 9086162.
    Citations: 4     Fields:    Translation:HumansCells
  56. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996 Nov 28; 335(22):1621-9. PMID: 8965861.
    Citations: 108     Fields:    Translation:HumansCellsCTClinical Trials
  57. Shapiro DE. Issues in combining independent estimates of the sensitivity and specificity of a diagnostic test. Acad Radiol. 1995 Mar; 2 Suppl 1:S37-47; discussion S65-9, S83. PMID: 9419704.
    Citations: 6     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Shapiro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (204)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.